The Scripps Research Institute board of trustees announced Tuesday that James Paulson, chair of the department of cell and molecular biology, has been appointed acting president and CEO.
Paulson takes over for Michael Marletta, who resigned in late July.
Paulson and the board of trustees will appoint members of a search committee and work with an executive search firm to find new leadership for the institute. The committee, which will include both faculty and trustees, will be chaired by Richard A. Gephardt, chair of the board of trustees.
Paulson, whose research program focuses on roles of glycan binding proteins in the immune system and adaptation of avian influenza viruses to humans, has been a full-time member of the Scripps Research Institute faculty since 1999.
In 2001, he became principal investigator of a large multi-year grant to create the Consortium for Functional Glycomics, now an organization with more than 650 participating investigators worldwide.
Prior to this, Paulson spent a decade with Cytel Corp., first as vice president for research and development and member of the board of directors, then chief scientific officer and the Board’s general manager.